Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center
Crossref DOI link: https://doi.org/10.1007/s40119-015-0046-y
Published Online: 2015-09-28
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sulica, Roxana
Fenton, Rebecca
Cefali, Frank
Funding for this research was provided by:
Bayer HealthCare (DE)